(Q33977623)

30 July 2017

title

Efficacious treatment of experimental leishmaniasis with amphotericin B-arabinogalactan water-soluble derivatives (English)

1 reference

30 July 2017

J Golenser

1

1 reference

30 July 2017

S Frankenburg

series ordinal

2

1 reference

30 July 2017

T Ehrenfreund

series ordinal

3

1 reference

30 July 2017

A J Domb

series ordinal

4

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 September 1999

1 reference

Antimicrobial Agents and Chemotherapy

30 July 2017

published in

1 reference

30 July 2017

volume

43

1 reference

30 July 2017

issue

9

1 reference

30 July 2017

page(s)

2209-2214

1 reference

A novel injectable water-soluble amphotericin B-arabinogalactan conjugate

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89448

Efficacies of KY62 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous leishmaniasis and visceral leishmaniasis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89448

Leishmania infantum: lack of parasite resistance to amphotericin B in a clinically resistant visceral leishmaniasis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89448

Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89448

Amphotericin B is superior to sodium antimony gluconate in the treatment of Indian post-kala-azar dermal leishmaniasis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89448

Comparison of the efficacies of various formulations of amphotericin B against murine visceral leishmaniasis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89448

Activity of a new liposomal formulation of amphotericin B against two strains of Leishmania infantum in a murine model

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89448

Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89448

Activity of liposomal amphotericin B against experimental cutaneous leishmaniasis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89448

Lipid formulations of amphotericin B: recent progress and future directions

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89448

Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azar

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89448

Pharmacokinetics and toxicity of continuous infusion amphotericin B in cancer patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89448

Lipid formulations of amphotericin b in the treatment of experimental visceral leishmaniasis due to Leishmania infantum

5 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10471566

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Release of amphotericin B from delivery systems and its action against fungal and mammalian cells

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10471566

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Treatment of visceral leishmaniasis in children with liposomal amphotericin B

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10471566

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

PMC publication ID

89448

1 reference

30 July 2017

1 reference